1000-7431
2016 Issue 6
Establishment of an anoikis-resistant colon carcinoma cell line and its biological characteristics
YANG Zhibin;ZHANG Hongtao;LI Qiang;XIAO Youchuan;LI Yunfeng;CHENG Xianshuo;HUANG Youguang;Colorectal Cancer Clinical Research Center;Third Affiliated Hospital of Kunming Medical University;Yunnan Cancer Hospital;Department of Tumor;Qujing First People’s Hospital;
YANG Zhibin;ZHANG Hongtao;LI Qiang;XIAO Youchuan;LI Yunfeng;CHENG Xianshuo;HUANG Youguang;Colorectal Cancer Clinical Research Center;Third Affiliated Hospital of Kunming Medical University;Yunnan Cancer Hospital;Department of Tumor;Qujing First People’s Hospital;
..............page:605-612
Expressions of nucleophosmin and c-Src in drug-resistant lung adenocarcinoma and its relationship with chemotherapy resistance
HE Jianbin;LIU Lijing;XIANG Zhi;YI Gaozhong;ZHANG Ping;Department of Respiration;First People’s Hospital of Huaihua;Department of Diagnosis;School of Clinical Medicine;Hunan Medicine College;Department of Respiration;First Affiliated Hospital;University of South China;
HE Jianbin;LIU Lijing;XIANG Zhi;YI Gaozhong;ZHANG Ping;Department of Respiration;First People’s Hospital of Huaihua;Department of Diagnosis;School of Clinical Medicine;Hunan Medicine College;Department of Respiration;First Affiliated Hospital;University of South China;
..............page:613-620
RNF181 gene-silencing promotes the proliferation of colorectal cancer SW480 cells
NIU Wenbo;WANG Suihai;LI Peng;WANG Mingqing;GAO Yanjun;DONG Ningning;HE Peirong;SHI Xiangyi;LI Jiliang;Antibody Engineering Institute;School of Biotechnology;Southern Medical University;School of Traditional Chinese Medicine;Southern Medical University;
NIU Wenbo;WANG Suihai;LI Peng;WANG Mingqing;GAO Yanjun;DONG Ningning;HE Peirong;SHI Xiangyi;LI Jiliang;Antibody Engineering Institute;School of Biotechnology;Southern Medical University;School of Traditional Chinese Medicine;Southern Medical University;
..............page:621-627
TPX2 gene-silencing inhibits the proliferation and invasion of human colon cancer SW480 cells
JIAN Jie;HUANG Yuan;LIU Lizhen;LI Shuang;DENG Feng;Department of Gastroenterology;Third Affiliated Hospital of Nanchang University;Department of Gastroenterology;Second Affiliated Hospital of Nanchang University;Department of Oncology;Jiading District Central Hospital of Shanghai;
JIAN Jie;HUANG Yuan;LIU Lizhen;LI Shuang;DENG Feng;Department of Gastroenterology;Third Affiliated Hospital of Nanchang University;Department of Gastroenterology;Second Affiliated Hospital of Nanchang University;Department of Oncology;Jiading District Central Hospital of Shanghai;
..............page:628-634
HOXA10 gene-silencing combined with tetramethylpyrazine reverses multidrug resistance of K562/ADR cells
JIA Xiuhong;YI Yingjie;REN Xiumin;WANG Jianyong;LI Youjie;Department of Pediatrics;Affiliated Hospital of Binzhou Medical University;Institute of Medical Molecular Genetics;Binzhou Medical University;
JIA Xiuhong;YI Yingjie;REN Xiumin;WANG Jianyong;LI Youjie;Department of Pediatrics;Affiliated Hospital of Binzhou Medical University;Institute of Medical Molecular Genetics;Binzhou Medical University;
..............page:635-643
Effects of Huaier Particles on the proliferation and apoptosis of human ovarian cancer SKOV3 cells in vitro
LIU Yu;ZHANG Yijun;LI Baoyu;CHEN Xiafei;WANG Ju;ZHOU Zongyao;Department of Histology and Embryology;Medical College of Shihezi University;Department of Pathology;Key Laboratory for Endemic and Ethnic Diseases;Medical College of Shihezi University;Department of Pharmacy;First Affiliated Hospital;Medical College of Shihezi University;Department of Clinical Medicine;Medical College of Shihezi University;
LIU Yu;ZHANG Yijun;LI Baoyu;CHEN Xiafei;WANG Ju;ZHOU Zongyao;Department of Histology and Embryology;Medical College of Shihezi University;Department of Pathology;Key Laboratory for Endemic and Ethnic Diseases;Medical College of Shihezi University;Department of Pharmacy;First Affiliated Hospital;Medical College of Shihezi University;Department of Clinical Medicine;Medical College of Shihezi University;
..............page:644-649
Association between rs11614913 polymorphism of microRNA-196a-2 gene and the susceptibility of gastric cancer:a Meta-analysis
YANG Dan;JIANG Lei;WEI Kongkong;CAO Dong;MA Xiaohui;GUAN Quanlin;SUN Huihui;GUO Shaojun;First Clinical Medical College of Lanzhou University;Department of Surgical Oncology;First Hospital of Lanzhou University;Second Clinical Medical College of Lanzhou University;
YANG Dan;JIANG Lei;WEI Kongkong;CAO Dong;MA Xiaohui;GUAN Quanlin;SUN Huihui;GUO Shaojun;First Clinical Medical College of Lanzhou University;Department of Surgical Oncology;First Hospital of Lanzhou University;Second Clinical Medical College of Lanzhou University;
..............page:650-658
Metformin and the risk of bladder cancer in patients with type 2 diabetes mellitus and its treatment efficacy:a Meta-analysis
DING Xianfei;DOU Mengmeng;ZHOU Xueliang;LI Lifeng;ZHANG Chaoqi;WANG Feng;CHI Yanyan;WU Shaoxuan;XU Zhentao;YUAN Bo;SHI Peina;ZHENG Shaohua;FAN Zhirui;ZHANG Yana;WANG Jun;Lü Zhuan;WANG Junsheng;YU Yanwu;SUN Mou;SUN Tongwen;FAN Qingxia;Department of Oncology;First Affiliated Hospital of Zhengzhou University;Department of Integrated Medicine;First Affiliated Hospital of Zhengzhou University;Biotherapy Center;First Affiliated Hospital of Zhengzhou University;Department of Surgical ICU;First Affiliated Hospital of Zhengzhou University;Department of Integrated ICU;First Affiliated Hospital of Zhengzhou University;
DING Xianfei;DOU Mengmeng;ZHOU Xueliang;LI Lifeng;ZHANG Chaoqi;WANG Feng;CHI Yanyan;WU Shaoxuan;XU Zhentao;YUAN Bo;SHI Peina;ZHENG Shaohua;FAN Zhirui;ZHANG Yana;WANG Jun;Lü Zhuan;WANG Junsheng;YU Yanwu;SUN Mou;SUN Tongwen;FAN Qingxia;Department of Oncology;First Affiliated Hospital of Zhengzhou University;Department of Integrated Medicine;First Affiliated Hospital of Zhengzhou University;Biotherapy Center;First Affiliated Hospital of Zhengzhou University;Department of Surgical ICU;First Affiliated Hospital of Zhengzhou University;Department of Integrated ICU;First Affiliated Hospital of Zhengzhou University;
..............page:659-667
Maintenance chemotherapy with S-1 following first-line regimen in patients with advanced esophageal cancer
SUN Jingbo;SONG Lijie;LI Xiangke;WANG Bo;FAN Qingxia;Department of Oncology;First Affiliated Hospital of Zhengzhou University;
SUN Jingbo;SONG Lijie;LI Xiangke;WANG Bo;FAN Qingxia;Department of Oncology;First Affiliated Hospital of Zhengzhou University;
..............page:668-673
Characteristics and clinical significance of CD45-negative microparticles and monocytes in breast cancer patients
WANG Ningfang;ZHAO Chongshan;LI Juan;HU Yanjie;ZHENG Fang;WANG Junfeng;HUANG Shiang;Department of Hematology;China National Petroleum Corporation Center Hospital;Department of Infection;China National Petroleum Corporation Center Hospital;Center of Stem Cell Research and Application;Union Hospital;Tongji Medical College;Huazhong University of Science and Technology;
WANG Ningfang;ZHAO Chongshan;LI Juan;HU Yanjie;ZHENG Fang;WANG Junfeng;HUANG Shiang;Department of Hematology;China National Petroleum Corporation Center Hospital;Department of Infection;China National Petroleum Corporation Center Hospital;Center of Stem Cell Research and Application;Union Hospital;Tongji Medical College;Huazhong University of Science and Technology;
..............page:674-682
Efficacy and prognosis of first-line chemotherapy with docetaxel monotherapy or docetaxel in combination with thiotepa in treatment of metastatic breast cancer
SHAO Bin;LI Huiping;DI Lijun;SONG Guohong;YAN Ying;WANG Huan;ZHANG Ruyan;WAN Fengling;YOU Miaoning;Department of Medical Oncology;Key Laboratory of Carcinogenesis and Translational Research;Peking University Cancer Hospital & Institute;
SHAO Bin;LI Huiping;DI Lijun;SONG Guohong;YAN Ying;WANG Huan;ZHANG Ruyan;WAN Fengling;YOU Miaoning;Department of Medical Oncology;Key Laboratory of Carcinogenesis and Translational Research;Peking University Cancer Hospital & Institute;
..............page:683-691
Expression and methylation status of IncRNA XLOC008370 in gastric cardia adenocarcinoma
SHEN Supeng;LIU Shengnan;KUANG Gang;SHI Yabin;LIANG Jia;GUO Wei;DONG Zhiming;QI Hailiang;Hebei Cancer Institute;Fourth Hospital of Hebei Medical University;Department of Thoracic Surgery;Hebei Chest Hospital;
SHEN Supeng;LIU Shengnan;KUANG Gang;SHI Yabin;LIANG Jia;GUO Wei;DONG Zhiming;QI Hailiang;Hebei Cancer Institute;Fourth Hospital of Hebei Medical University;Department of Thoracic Surgery;Hebei Chest Hospital;
..............page:692-697
Phamacoeconomics evaluation of nilotinib and dasatinib in second-line treament of chronic mycloid leukemia therapy
CHEN Lin;YANG Min;CHENG Guohua;First Affiliated Hospital;Jinan University;College of Pharmacy;Jinan University;
CHEN Lin;YANG Min;CHENG Guohua;First Affiliated Hospital;Jinan University;College of Pharmacy;Jinan University;
..............page:698-704+710
Lay further emphasis on the nutrition support therapy for cancer patients
CHEN Bo;XIONG Maoming;MENG Xiangling;Department of Gastrointestinal Surgery;First Affiliated Hospital of Anhui Medical University;Anhui Medical University;
CHEN Bo;XIONG Maoming;MENG Xiangling;Department of Gastrointestinal Surgery;First Affiliated Hospital of Anhui Medical University;Anhui Medical University;
..............page:705-710
Indoleamine 2,3-dioxygenase:a new target in multidimensional therapy mode for malignant tumors
CHU Songlin;LI Lijuan;ZHANG Liansheng;PENG Minmin;Department of Hematology;Lanzhou University Second Hospital;
CHU Songlin;LI Lijuan;ZHANG Liansheng;PENG Minmin;Department of Hematology;Lanzhou University Second Hospital;
..............page:711-717
The advances in cancer stem cells and radiation resistance
CHEN Mengting;HUANG Qian;Department of Oncology;Shanghai First People’s Hospital;
CHEN Mengting;HUANG Qian;Department of Oncology;Shanghai First People’s Hospital;
..............page:718-722